Article Information
Published By
History
- Received January 26, 2026
- Accepted March 6, 2026
- Published online April 16, 2026.
Copyright & Usage
Copyright: © 2026, The Authors This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License.
Author Information
Funding
National Natural Science Foundation of China
82202837Noncommunicable Chronic Diseases-National Science and Technology Major Project
2025ZD0545200Noncommunicable Chronic Diseases-National Science and Technology Major Project
2023ZD0501400National Natural Science Foundation of China
82421002National Natural Science Foundation of China
82350122National Key R&D Program of China
2022YFC2505100Postdoctoral Fellowship Program of CPSF
GZC20242251China Postdoctoral Science Foundation
2024M754223
This work was supported by the National Natural Science Foundation of China (Grant No. 82202837), the Noncommunicable Chronic Diseases-National Science and Technology Major Project (Grant Nos. 2025ZD0545200, and 2023ZD0501400), the National Natural Science Foundation of China (Grant Nos. 82421002 and 82350122), the National Key R&D Program of China (Grant No. 2022YFC2505100), the Postdoctoral Fellowship Program of CPSF (Grant No. GZC20242251), and the China Postdoctoral Science Foundation (Grant No. 2024M754223).
In this issue
Jump to section
- Article
- FMRS predicts TLS classification from CT images
- Prognostic value of FMRS for overall survival (OS) and disease-free survival (DFS)
- FMRS as a predictive biomarker of benefit from adjuvant chemotherapy
- FMRS status predicts response and survival benefit from neoadjuvant therapy
- Supporting Information
- Conflict of interest statement
- Author contributions
- Data availability statement
- References
- Figures & Data
- Info & Metrics
- References
Related Articles
Cited By...
- No citing articles found.